1. Home
  2. QURE vs FMBH Comparison

QURE vs FMBH Comparison

Compare QURE & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • FMBH
  • Stock Information
  • Founded
  • QURE 1998
  • FMBH 1865
  • Country
  • QURE Netherlands
  • FMBH United States
  • Employees
  • QURE N/A
  • FMBH N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • FMBH Major Banks
  • Sector
  • QURE Health Care
  • FMBH Finance
  • Exchange
  • QURE Nasdaq
  • FMBH Nasdaq
  • Market Cap
  • QURE 725.4M
  • FMBH 853.8M
  • IPO Year
  • QURE 2007
  • FMBH N/A
  • Fundamental
  • Price
  • QURE $14.24
  • FMBH $37.70
  • Analyst Decision
  • QURE Strong Buy
  • FMBH Hold
  • Analyst Count
  • QURE 10
  • FMBH 5
  • Target Price
  • QURE $37.20
  • FMBH $44.00
  • AVG Volume (30 Days)
  • QURE 1.3M
  • FMBH 79.8K
  • Earning Date
  • QURE 07-31-2025
  • FMBH 07-31-2025
  • Dividend Yield
  • QURE N/A
  • FMBH 2.51%
  • EPS Growth
  • QURE N/A
  • FMBH 8.80
  • EPS
  • QURE N/A
  • FMBH 3.37
  • Revenue
  • QURE $20,201,000.00
  • FMBH $321,695,000.00
  • Revenue This Year
  • QURE N/A
  • FMBH N/A
  • Revenue Next Year
  • QURE $278.91
  • FMBH $4.02
  • P/E Ratio
  • QURE N/A
  • FMBH $11.34
  • Revenue Growth
  • QURE 6.30
  • FMBH 11.71
  • 52 Week Low
  • QURE $3.73
  • FMBH $27.58
  • 52 Week High
  • QURE $19.18
  • FMBH $43.86
  • Technical
  • Relative Strength Index (RSI)
  • QURE 45.40
  • FMBH 62.20
  • Support Level
  • QURE $13.65
  • FMBH $36.53
  • Resistance Level
  • QURE $15.35
  • FMBH $37.35
  • Average True Range (ATR)
  • QURE 0.90
  • FMBH 0.99
  • MACD
  • QURE -0.28
  • FMBH 0.12
  • Stochastic Oscillator
  • QURE 14.68
  • FMBH 99.18

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

Share on Social Networks: